kabutan

D.Western Therapeutics Institute, Jan-Sep (Cumulative 3Q) Net Income Loss Narrows, Jul-Sep Net Income Loss Narrows

Thu Nov 13, 2025 3:30 pm JST Earnings

4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】

Earnings Report

D.Western Therapeutics Institute, Inc. <4576> [TSE Growth] announced its financial results after the market closed on November 13th (15:30). The consolidated net loss for the cumulative third quarter of the fiscal year ending December 2025 (January to September) was a reduced loss of 492 million yen (compared to a loss of 727 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the October to December period (4Q) is expected to further decrease loss of 188 million yen (compared to a loss of 563 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated net loss improved to a deficit of 176 million yen (compared to a loss of 207 million yen in the same period last year). The operating profit/loss margin improved from -158.4% in the same period last year to -136.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2023 313 -457 -453 -443 -14.0 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 348 -647 -665 -727 -21.6 ー Nov 14, 2024 J-GAAP
Jan - Sep, 2025 297 -478 -491 -492 -10.8 ー Nov 13, 2025 J-GAAP
YoY -14.7% +26.1% +26.2% +32.3% +50.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 248 -760 -769 -770 -21.9 0 Feb 10, 2025 J-GAAP
Jul - Dec, 2025 Guidance 227 -361 -364 -364 -6.7 0 Aug 14, 2025 J-GAAP
YoY -8.5% +52.5% +52.7% +52.7% +69.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 428 -798 -796 -812 -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 400 -670 -680 -680 -12.6 0 Feb 10, 2025 J-GAAP
YoY -15.1% +44.6% +44.6% +47.3% +65.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 125 -198 -206 -207 -6.2 -158.4 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 123 -562 -563 -563 -16.0 -456.9 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 96 -142 -149 -150 -3.4 -147.9 May 15, 2025 J-GAAP
Apr - Jun, 2025 77 -167 -167 -166 -3.7 -216.9 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 124 -169 -175 -176 -3.9 -136.3 Nov 13, 2025 J-GAAP
YoY -0.8% +14.6% +15.0% +15.0% +37.4%

Related Articles